Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Radiation × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 14 Glioblastoma 14 Breast Neoplasms 12 Lung Neoplasms 9 Oropharyngeal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Astrocytoma 6 Urinary Bladder Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 4 Brain Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma, Ewing 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Gliosarcoma 3 Glioma 3 Carcinoma, Squamous Cell 3 Carcinoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Prostate Adenocarcinoma 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Medulloblastoma 2

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡